Literature DB >> 2944623

Induction of tolerance via skin depleted of Langerhans cells by a chemical carcinogen.

G M Halliday, H K Muller.   

Abstract

Since treatment of mouse skin with the chemical carcinogen 7,12-dimethylbenz[alpha]anthracene (DMBA) substantially decreases the density of cutaneous Langerhans cells (LC), the immune status of mice sensitized to 2,4-dinitrofluorobenzene (DNFB) through DMBA-treated skin was investigated. Mice did not develop contact sensitivity to DNFB when applied to DMBA-treated dorsal trunk skin, whereas sensitization resulted when DNFB was applied to untreated abdominal wall skin. Mice immunized with DNFB via DMBA-treated skin did not respond to subsequent immunization through untreated dorsal trunk skin, demonstrating the generation of suppressor cells which could inhibit the activation of effector lymphocytes. Adoptively transferred spleen cells from mice immunized with DNFB through DMBA-treated skin inhibited the response of sensitized hosts, indicating the presence of efferently acting suppressor cells which could inhibit the function of effector lymphocytes. This study has demonstrated that sensitization via skin depleted of LC by chemical carcinogen treatment induces an active state of tolerance rather than immunity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2944623     DOI: 10.1016/0008-8749(86)90230-3

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  11 in total

1.  Acquisition of immune function during the development of the Langerhans cell network in neonatal mice.

Authors:  A L Dewar; K V Doherty; G M Woods; A B Lyons; H K Muller
Journal:  Immunology       Date:  2001-05       Impact factor: 7.397

2.  Carcinogen-modified dendritic cells induce immunosuppression by incomplete T-cell activation resulting from impaired antigen uptake and reduced CD86 expression.

Authors:  G M Woods; K V Doherty; R C Malley; M J Rist; H K Muller
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

3.  Presentation of antigen to suppressor cells by a dimethylbenz (a) anthracene-resistant, Ia-positive, Thy-1-negative, I-J-restricted epidermal cell.

Authors:  G M Halliday; R C Wood; H K Muller
Journal:  Immunology       Date:  1990-01       Impact factor: 7.397

4.  Topical and oral retinoids protect Langerhans' cells and epidermal Thy-1+ dendritic cells from being depleted by ultraviolet radiation.

Authors:  K K Ho; G M Halliday; R S Barnetson
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

5.  The effect of cryo-treatment on epidermal Langerhans cells and immune function in mice.

Authors:  T Horio; H Miyauchi; Y K Kim; Y Asada
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

6.  Effects of gliotoxin on Langerhans' cell function: contact hypersensitivity responses and skin graft survival.

Authors:  P C McMinn; G M Halliday; H K Muller
Journal:  Immunology       Date:  1990-09       Impact factor: 7.397

7.  A role for prostaglandins in the suppression of cutaneous cellular immunity and tumour development in benzo(a)pyrene- but not dimethylbenz(a)anthracene-treated mice.

Authors:  J Andrews; G M Halliday; H K Muller
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

8.  Retinoic acid protects Langerhans' cells from the effects of the tumour promotor 12-O-tetradecanoylphorbol 13-acetate.

Authors:  G M Halliday; J L Dickinson; H K Muller
Journal:  Immunology       Date:  1989-07       Impact factor: 7.397

Review 9.  Hazardous air pollutants and asthma.

Authors:  George D Leikauf
Journal:  Environ Health Perspect       Date:  2002-08       Impact factor: 9.031

Review 10.  Evaluation of a possible association of urban air toxics and asthma.

Authors:  G D Leikauf; S Kline; R E Albert; C S Baxter; D I Bernstein; J Bernstein; C R Buncher
Journal:  Environ Health Perspect       Date:  1995-09       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.